Illnesses and conditions

A landmark study has found that a workable exercise plan significantly improves survival and health of people who have survived colorectal cancer. So much so that, as one researcher notes, "Our findings will change the way we treat colon cancer."

Diabetic foot ulcers are prone to recurring, even when they look healed. A new study used an existing method to assess the degree of water loss from the skin and found that it was a good diagnostic tool for predicting a foot ulcer’s comeback.

A new study has found that, for most of us, the fiber we eat can protect our heart health, lowering the risk of high blood pressure, heart disease or stroke by up to 20%. It’s more evidence showing that a healthy gut leads to a healthy heart.

A new study has found that smoking marijuana and ingesting THC edibles over the long term can reduce blood vessel function at levels similar to those seen in cigarette smokers, posing a risk to heart health.

A paradigm shift in the way we treat spinal injuries is now in sight, with the world's first regenerative cell therapy approved for a Phase I clinical trial. It's a historical milestone that could reverse what has, until now, been an incurable injury.

Positive results from trials of an immune therapy in dogs with bone cancer have been used to fast-track the development of the drug to treat children with the same cancer. It highlights how leveraging our genetic similarity can advantage both species.

A new study found that non-invasive in-ear electrical stimulation to the vagus nerve safely and effectively reduces osteoarthritis-related knee pain. It opens the door to innovative, quality-of-life-improving treatment.

A new experimental painkiller has shown promise in dulling or eliminating pain without the addictive qualities exhibited by today's most popular opioids. The drug also sidesteps common opioid side effects like constipation and sedation.

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published, examining their ability to reduce weight and waist circumference. And one clearly comes out on top.

High blood sugars have long been known to cause eye damage in diabetics. However, new research has found that low blood sugar may also contribute. The good news is that it also identified a way of preventing or treating the damage.

Using an existing steroid-free topical foam daily significantly improved the signs and symptoms of psoriasis on the scalp and the body, according to a recent clinical trial. It could be a game-changer for people with the condition in both places.

Following on from a remarkable study in mice, scientists have now confirmed that silencing a certain protein in muscle tissue leads to energy-deprived human cells seeking out fat for fuel, while blocking the body's ability to store extra fat cells.

Clinical trials of a minimally invasive treatment for degenerated spinal discs have produced impressive results, significantly reducing back pain severity and improving function. It may mean delaying surgical intervention or preventing it altogether.

What if the key to reducing your chronic pain was not in tackling the symptoms, but in regulating your emotions? A study shows that retraining your brain to deescalate negative emotions could be an effective therapy for persistent pain.

The first once-daily oral GLP-1 medication could be on shelves by this time next year, making the weight-loss drug easier to take and potentially cheaper. In the race to be the first, Novo Nordisk has scored a huge win, while Pfizer has failed again.